Gsk (GSK) Revenue (2009 - 2026)
Gsk (GSK) posted quarterly Revenue of $11.3 billion for Q2 2026, up 5.9% year-over-year from $10.7 billion in Q2 2025, and up 9.69% quarter-over-quarter from $10.3 billion in Q1 2026.
Gsk (GSK) Revenue (2009 - 2026) Analysis & Trends
Gsk's Revenue history runs 18 years deep, the most recent figure standing at $11.3 billion for Q2 2026.
- In Q2 2026, Revenue rose 5.9% year-over-year to $11.3 billion; the TTM figure through Jun 2026 stood at $53.7 billion (up 7.23% YoY), while the FY2025 annual figure was $43.1 billion, up 7.39% from the prior year.
- Revenue for Q2 2026 stood at $11.3 billion, up from $10.3 billion in the prior quarter.
- The five-year high for Revenue was $20.6 billion in Q4 2025, with the low at $8.4 billion in Q1 2023.
- The 5-year median for Revenue is $10.3 billion (2023), against an average of $11.8 billion.
- Peak annual rise in Revenue reached 35.73% in 2022, while the deepest fall reached 50.25% in 2022.
- Gsk's Revenue stood at $16.6 billion in 2022, then increased by 5.89% to $17.5 billion in 2023, then grew by 11.59% to $19.6 billion in 2024, then grew by 5.37% to $20.6 billion in 2025, then sank by 45.29% to $11.3 billion in 2026.
- Business Quant data shows GSK's Revenue at $11.3 billion in Q2 2026, $10.3 billion in Q1 2026, and $20.6 billion in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 645.88 Bn | 625.12 Bn | 17.26 Bn | 25.31 Bn |
| 2 | AbbVie | 463.46 Bn | 456.89 Bn | 12.70 Bn | 16.99 Bn |
| 3 | Merck | 367.92 Bn | 360.78 Bn | 12.21 Bn | 16.61 Bn |
| 4 | Novartis Ag | 297.71 Bn | 290.02 Bn | 11.24 Bn | 14.41 Bn |
| 5 | Astrazeneca | 255.55 Bn | 250.65 Bn | 12.86 Bn | 15.38 Bn |
| 6 | Amgen | 234.52 Bn | 220.53 Bn | 7.24 Bn | 10.05 Bn |
| 7 | Gilead Sciences | 178.22 Bn | 175.04 Bn | 6.22 Bn | 7.80 Bn |
| 8 | Pfizer | 158.57 Bn | 146.88 Bn | 10.94 Bn | 15.03 Bn |
| 9 | Gsk | 105.32 Bn | 101.15 Bn | 8.24 Bn | 11.28 Bn |
| 10 | Sanofi | 54.20 Bn | 46.82 Bn | 10.79 Bn | 13.48 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 11.28 Bn |
| Mar 31, 2026 | 10.29 Bn |
| Dec 31, 2025 | 20.62 Bn |
| Sep 30, 2025 | 11.53 Bn |
| Jun 30, 2025 | 10.65 Bn |
| Mar 31, 2025 | 9.47 Bn |
| Dec 31, 2024 | 19.57 Bn |
| Sep 30, 2024 | 10.41 Bn |
| Jun 30, 2024 | 9.95 Bn |
| Mar 31, 2024 | 9.34 Bn |
| Dec 31, 2023 | 17.54 Bn |
| Sep 30, 2023 | 10.32 Bn |
| Jun 30, 2023 | 8.98 Bn |
| Mar 31, 2023 | 8.45 Bn |
| Dec 31, 2022 | 16.56 Bn |
| Sep 30, 2022 | 9.23 Bn |
| Jun 30, 2022 | 8.73 Bn |
| Mar 31, 2022 | 9.65 Bn |
| Dec 31, 2021 | 33.29 Bn |
| Sep 30, 2021 | 9.14 Bn |